论文部分内容阅读
在新世纪来临的前夜,从大洋彼岸传来了令人鼓舞的喜讯:一种全新的抗癌物质一SBA(小分子生物合成抗癌因子的英文缩写)问世了!1998年11月,在美国洛杉矶举行的“新型抗癌物质SBA研究成果报告会”上,波士顿大学医学教授、致癌基因研究专家肖志雄博士郑重向新闻界宣告:SBA能够同时诱导多种癌细胞自行凋亡,而正常细胞则安然无恙……之后,来自美国南加州大学医学院病理实验室、美国圣地亚哥抗癌公司和我国福建医科大学药理教研室的实验报告相继证明了这一消息的可靠性。一时间,SBA及其发明者——我国女科学家杨振华成了人们关注的焦点。
On the eve of the advent of the new century, encouraging news from the other side of the ocean came: a new anti-cancer substance-SBA (small molecule biosynthesis anticancer factor abbreviation) came out! November 1998, in the United States Los Angeles held a “report of the new anti-cancer substance SBA research results”, Boston University professor of medicine, oncogene research expert Dr. Xiao Zhixiong solemnly declared to the press: SBA can simultaneously induce a variety of cancer cells apoptosis, while normal cells are Safe and sound ... After that, from the United States University of Southern California Medical College Pathology Laboratory, the United States San Diego Cancer Institute and Fujian Medical University, Department of Pharmacology, laboratory reports have confirmed the reliability of the news. For a time, SBA and its inventor Yang Zhenhua, a Chinese female scientist, became the focus of attention.